Aleplasinin
Aleplasinin (PAZ 417) is an orally bioavailable, selective inhibitor of plasminogen activator inhibitor-1 (PAI-1), a primary regulator of fibrinolysis. Its application in research includes in vitro enzymatic assays and in vivo models for studying Alzheimer's disease pathology and other conditions involving impaired fibrinolytic activity.
Product Specifications
CAS Number
481629-87-2
Product Name Alternative
BBB-penetrated, Amyloid-β, Aleplasinin, Alzheimer's disease, Abeta, PAZ 417, PAZ417, PAZ-417, PAI1, PAI-1, inhibit, memory deficiency, Inhibitor, Plasminogen activator inhibitor-1, orally active, Serpin family, β-amyloid peptide
Field of Research
Metabolism Research, Neuroscience
Purity
97.51% (May vary between batches)
Solubility
DMSO:245 mg/mL (575.77 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:5 mg/mL (11.75 mM)
Smiles
Cc1cccc (c1) -c1ccc2n (Cc3ccc (cc3) C (C) (C) C) cc (C (=O) C (O) =O) c2c1
Molecular Formula
C28H27NO3
Molecular Weight
425.52
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ELI-38145h 96 Tests
Human Uncharacterized protein KIAA1467, KIAA1467 ELISA KIT
Sign In for Pricing
View Details 
EIA06695Ca 1 Kit
Canine Rap1 GTPase-GDP dissociation stimulator 1 (RAP1GDS1) ELISA Kit
Sign In for Pricing
View Details 
LV649190 1.0 µg DNA
ANGPTL3 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA)
Sign In for Pricing
View Details